Randox Offers New Drug of Abuse Antibodies
Randox Life Sciences has developed an extensive range of drug-targeted antibodies for research and development applications.
Read MoreMonth: June 2011
Danaher Corp to Acquire Beckman Coulter
Djanet Acquisition Corp has successfully purchased all of the shares duly tendered and not withdrawn pursuant to its tender offer for all of the outstanding shares of Beckman Coulter Inc common stock at $83.50 per share, net to the seller in cash without interest and less any applicable withholding taxes.
Read MorePoll: Nearly One in Three Adults Over 50 Not Screened for Colon Cancer
Results from a nationwide research poll released by the Colon Cancer Alliance and Quest Diagnostics show that 31% of men and women age 50 years and over have never been screened for colon cancer by standard screening methods.
Read MoreResonetics Opens New Facility in New Hampshire
The company’s thriving business operations spurred the move, and further expansion is planned.
Read MoreRoche, Evotec to Jointly Develop Biomarkers in Oncology
Roche and Evotec AG today will collaborate on protein-activity based biomarkers for Roche’s oncology drugs under development.
Read More